Global Viral And Non Viral Vector Manufacturing Market Report 2024

Viral And Non-Viral Vector Manufacturing Global Market Report 2024 – By Vector Type (Viral Vector, Non-Viral Vector), By Disease (Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases), By Application (Gene Therapy, Vaccinology, Cell Therapy, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Viral And Non-Viral Vector Manufacturing Global Market Report 2024

Starting Price : $5000.00 | Pages : | Published : January 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options
Request Sample
Request For Discount
FAQs
Customise Your Report
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying
Viral And Non-Viral Vector Manufacturing Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

Viral And Non-Viral Vector Manufacturing Market Definition And Segments

Viral and non-viral vector manufacturing refers to producing viral and non-viral vectors, tools that deliver genetic material into cells. Viral vectors treat human diseases and are used in anticancer and gene therapies. Non-viral vectors are utilized for a variety of gene therapy applications, particularly for the creation of vaccines and the treatment of cancer.

The main types of viral and non-viral vector manufacturing vectors are viral vectors and non-viral vectors. A viral vector refers to a method commonly employed in gene therapy and gene editing to add therapeutic genes or change how existing genes are expressed in living things. The various diseases are cancer, genetic disease, infectious disease, cardiovascular disease, and others applied in gene therapy, vaccinology, cell therapy, and others.

The viral and non-viral vector manufacturing market covered in this report is segmented –

1) By Vector Type: Viral Vector, Non-Viral Vector

2) By Disease: Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases

3) By Application: Gene Therapy, Vaccinology, Cell Therapy, Other Applications

The viral and non-viral vector manufacturing market size has grown rapidly in recent years. It will grow from $7.22 billion in 2023 to $8.62 billion in 2024 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be attributed to the rising prevalence of genetic disorders, advancements in biotechnology, increasing investments in gene therapy research, growing awareness of personalized medicine, and regulatory support for gene therapy development.

The viral and non-viral vector manufacturing market size is expected to see rapid growth in the next few years. It will grow to $17.85 billion in 2028 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to rising demand for gene therapies, expanding applications in rare disease treatment, increasing investments in biomanufacturing infrastructure, and growing adoption of precision medicine. Major trends in the forecast period include the development of next-generation viral vectors, increased use of CRISPR or cas9 technology in vector manufacturing, focus on scalable and cost-effective manufacturing processes, rising adoption of non-viral vectors, and advancements in cell and gene therapy manufacturing technologies.

The Rise Of Vector Therapies In Genetic Disorder Treatment

The increasing prevalence of genetic disorders is expected to propel the growth of the viral and non-viral vector manufacturing markets going forward. Genetic disorders refer to a condition entirely or partially brought on by a deviation from the typical DNA sequence. Viral vectors deliver therapeutic genes to target cells, replacing or supplementing the defective genes that cause genetic disorders. Non-viral vectors are often used in ex vivo gene therapy approaches, where cells are genetically modified outside the body and then reinfused into the patient. For instance, in June 2023, according to Versus Arthritis, a UK-based charity dedicated to supporting people with arthritis, in 2021, around 450,000 people will have rheumatoid arthritis, 190,000 adults will have psoriatic arthritis, and 10 million people will have osteoarthritis, compared to 430,000 people with rheumatoid arthritis, 100,000 adults with psoriatic arthritis, and 8.5 million people with osteoarthritis in 2021, respectively. Furthermore, in June 2022, according to the International Diabetes Federation, a Belgium-based diabetes federation, the prevalence of diabetes had increased to 10.5% worldwide, with over half (44.7%) of people still undiagnosed and around 783 million adults, or one in eight people, expected to have diabetes by 2045. Therefore, the increasing incidence of genetic disorders drives the growth of the viral and non-viral vector manufacturing market.

Clinical Trial Surges Fuel Viral And Non-Viral Vector Manufacturing Growth

The rising number of clinical trials is expected to propel the growth of the viral and non-viral vector manufacturing markets going forward. Clinical trials are research studies conducted with human participants to evaluate the safety, efficacy, and potential side effects of a medical intervention, treatment, or drug. Viral and non-viral vector manufacturing is indispensable in supporting gene therapy clinical trials by providing the necessary tools for delivering therapeutic genes to patients and ensuring the safety, quality, and scalability of these vectors throughout the trial phases. For instance, in December 2023, according to ClinicalTrials.gov, a US-based web-based resource maintained by the US National Library of Medicine, providing information on clinical trials in the year 2022, a total of 437,515 clinical trials were registered, and among them, 56,561 were completed. Moving into 2023, as of December 20, there has been an increase in both registration and completion figures. Specifically, 476,626 clinical trials have been registered, with 61,504 trials already completed. Therefore, the rising number of clinical trials is driving the growth of the viral and non-viral vector manufacturing markets.

Major companies operating in the viral and non-viral vector manufacturing market report are Novartis AG, Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Lonza Group AG, WuXi AppTec Co Ltd., Catalent Inc., Sartorius AG, Charles River Laboratories Inc., Sarepta Therapeutics Inc., GenScript ProBio Co. Ltd., TAKARA BIO Inc., Oxford BioMedica PLC, Beam Therapeutics Inc., Intellia Therapeutics Inc., MaxCyte Inc., Voyager Therapeutics Inc., Genethon, MeiraGTx Holdings PLC, Evox Therapeutics Ltd., Entos Pharmaceuticals Inc., LogicBio Therapeutics Inc., bluebird bio Inc., 4D Molecular Therapeutics Inc., Precision NanoSystems Inc., GenSight Biologics S.A., Abeona Therapeutics Inc., Generation Bio Co.

Merck KGaA’s Breakthrough In Viral And Non-Viral Solutions

Technological advancements are a key trend gaining popularity in the viral and non-viral vector manufacturing markets. Major companies operating in the viral and non-viral vector manufacturing markets are developing technologically advanced solutions to sustain their position in the market. For instance, in August 2022, Merck KGaA, a Germany-based science and technology company, launched the VirusExpress 293 Adeno-Associated Virus (AAV) Production Platform. One of the first Contract development and manufacturing organizations and technology creators to offer an entire viral vector manufacturing package, including AAV, Lentiviral, CDMO, CTO, and process development. With the help of this innovative platform, biopharmaceutical businesses may shorten the time and expense of process development while accelerating the time to clinical manufacture.

Advancing Vector Technology For Enhanced Gene And Cell Therapies

Major companies operating in the viral and non-viral vector manufacturing market are focused on partnerships to increase their profitability in the market. Collaborative partnerships in viral and non-viral vector manufacturing involve biopharmaceutical companies, CDMOs, research institutions, and technology providers working together to enhance the efficiency, safety, and scalability of non-viral vector development and production. For instance, in September 2023, NecstGen, a Netherland-based CDMO providing comprehensive support for all developers in the field of Cell and Gene Therapy collaborated with ProteoNic BioSciences, a Netherland-based technology provider for the production of complex therapeutic proteins and launched ProteoNic's 2G UNic premium vector technology. The successful application of this technology has enhanced the development of lentiviral (LV) vectors, boosting functional viral particle titers and directly improving process efficiency, thereby increasing the cost-effectiveness and accessibility of therapies. This versatile technology extends to various applications, including gene therapy viral vector production, mRNA therapeutics, and transient protein production. By advancing AAV and LV viral vector manufacturing technology for both transient systems and stable producer cell lines, this development has the potential to benefit viral vector manufacturing for gene therapies and non-vector processes, offering potential benefits across diverse applications.

Thermo Fisher’s Game-Changing Acquisition Of Henogen S.A.

In January 2021, Thermo Fisher Scientific Inc., a US-based supplier of software, services, analytical tools, reagents and consumables, and medical equipment, acquired Henogen S.A. for $874.5 million. With this acquisition, Thermo Fisher Scientific Inc. aims to increase its capacity for cell and gene therapies and vaccines worldwide. Henogen S.A. is a Belgium-based biomanufacturing company offering bioprocess development and viral vector manufacturing services.

North America was the largest region in the viral and non-viral vector manufacturing market in 2023. The regions covered in the viral and non-viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the viral and non-viral vector manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The viral and non-viral vector manufacturing market includes revenues earned by entities by providing adeno-associated viral vectors, lentiviral vectors, retroviral vectors, adenoviral vectors, particle-based vectors, and chemical-based vectors. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The viral and non-viral vector manufacturing vectors market research report is one of a series of new reports from The Business Research Company that provides viral and non-viral vector manufacturing vectors market statistics, including viral and non-viral vector manufacturing vectors industry global market size, regional shares, competitors with a viral and non-viral vector manufacturing vectors market share, detailed viral and non-viral vector manufacturing vectors market segments, market trends and opportunities, and any further data you may need to thrive in the viral and non-viral vector manufacturing vectors industry. This viral and non-viral vector manufacturing vectors market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Viral And Non-Viral Vector Manufacturing Market Report Scope
Report AttributeDetails
Market Size Value In 2024 $8.62 billion
Revenue Forecast In 2033 $17.85 billion
Growth Rate CAGR of 20% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Vector Type: Viral Vector, Non-Viral Vector
2) By Disease: Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases
3) By Application: Gene Therapy, Vaccinology, Cell Therapy, Other Applications
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope Australia; China; India; Indonesia; Japan; South Korea; Bangladesh; Thailand; Vietnam; Malaysia; Singapore; Philippines; Hong Kong; New Zealand; USA; Canada; Mexico; Brazil; Chile; Argentina; Colombia; Peru; France; Germany; UK; Austria; Belgium; Denmark; Finland; Ireland; Italy; Netherlands; Norway; Portugal; Spain; Sweden; Switzerland; Russia; Czech Republic; Poland; Romania; Ukraine; Saudi Arabia; Israel; Iran; Turkey; UAE; Egypt; Nigeria; South Africa
Key Companies Profiled Novartis AG; Thermo Fisher Scientific Inc.; Merck KGaA; FUJIFILM Holdings Corporation; Regeneron Pharmaceuticals Inc.; Astellas Pharma Inc.; Lonza Group AG; WuXi AppTec Co Ltd.; Catalent Inc.; Sartorius AG; Charles River Laboratories Inc.; Sarepta Therapeutics Inc.; GenScript ProBio Co. Ltd.; TAKARA BIO Inc.; Oxford BioMedica plc; Beam Therapeutics Inc.; Intellia Therapeutics Inc.; MaxCyte Inc.; Voyager Therapeutics Inc.; Genethon; MeiraGTx Holdings plc; Evox Therapeutics Ltd.; Entos Pharmaceuticals Inc.; LogicBio Therapeutics Inc.; bluebird bio Inc.; 4D Molecular Therapeutics Inc.; Precision NanoSystems Inc.; GenSight Biologics S.A.; Abeona Therapeutics Inc.; Generation Bio Co.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Viral And Non-Viral Vector Manufacturing Market Characteristics

    3. Viral And Non-Viral Vector Manufacturing Market Trends And Strategies

    4. Viral And Non-Viral Vector Manufacturing Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Viral And Non-Viral Vector Manufacturing Market Size and Growth

    5.1. Global Viral And Non-Viral Vector Manufacturing Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Viral And Non-Viral Vector Manufacturing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Viral And Non-Viral Vector Manufacturing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Viral And Non-Viral Vector Manufacturing Market Segmentation

    6.1. Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Viral Vector

    Non-Viral Vector

    6.2. Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Cancer

    Genetic Disease

    Infectious Disease

    Cardiovascular Disease

    Other Diseases

    6.3. Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Gene Therapy

    Vaccinology

    Cell Therapy

    Other Applications

    7. Viral And Non-Viral Vector Manufacturing Market Regional And Country Analysis

    7.1. Global Viral And Non-Viral Vector Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Viral And Non-Viral Vector Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Viral And Non-Viral Vector Manufacturing Market

    8.1. Asia-Pacific Viral And Non-Viral Vector Manufacturing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Viral And Non-Viral Vector Manufacturing Market

    9.1. China Viral And Non-Viral Vector Manufacturing Market Overview

    9.2. China Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Viral And Non-Viral Vector Manufacturing Market

    10.1. India Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Viral And Non-Viral Vector Manufacturing Market

    11.1. Japan Viral And Non-Viral Vector Manufacturing Market Overview

    11.2. Japan Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Viral And Non-Viral Vector Manufacturing Market

    12.1. Australia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Viral And Non-Viral Vector Manufacturing Market

    13.1. Indonesia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Viral And Non-Viral Vector Manufacturing Market

    14.1. South Korea Viral And Non-Viral Vector Manufacturing Market Overview

    14.2. South Korea Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Viral And Non-Viral Vector Manufacturing Market

    15.1. Western Europe Viral And Non-Viral Vector Manufacturing Market Overview

    15.2. Western Europe Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Viral And Non-Viral Vector Manufacturing Market

    16.1. UK Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Viral And Non-Viral Vector Manufacturing Market

    17.1. Germany Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Viral And Non-Viral Vector Manufacturing Market

    18.5. France Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.6. France Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.7. France Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Viral And Non-Viral Vector Manufacturing Market

    19.9. Italy Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.10. Italy Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.11. Italy Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Viral And Non-Viral Vector Manufacturing Market

    20.13. Spain Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.14. Spain Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.15. Spain Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Viral And Non-Viral Vector Manufacturing Market

    21.1. Eastern Europe Viral And Non-Viral Vector Manufacturing Market Overview

    21.2. Eastern Europe Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Viral And Non-Viral Vector Manufacturing Market

    22.1. Russia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Viral And Non-Viral Vector Manufacturing Market

    23.1. North America Viral And Non-Viral Vector Manufacturing Market Overview

    23.2. North America Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Viral And Non-Viral Vector Manufacturing Market

    24.1. USA Viral And Non-Viral Vector Manufacturing Market Overview

    24.2. USA Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Viral And Non-Viral Vector Manufacturing Market

    25.1. Canada Viral And Non-Viral Vector Manufacturing Market Overview

    25.2. Canada Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Viral And Non-Viral Vector Manufacturing Market

    26.1. South America Viral And Non-Viral Vector Manufacturing Market Overview

    26.2. South America Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Viral And Non-Viral Vector Manufacturing Market

    27.1. Brazil Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Viral And Non-Viral Vector Manufacturing Market

    28.1. Middle East Viral And Non-Viral Vector Manufacturing Market Overview

    28.2. Middle East Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Viral And Non-Viral Vector Manufacturing Market

    29.1. Africa Viral And Non-Viral Vector Manufacturing Market Overview

    29.2. Africa Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Viral And Non-Viral Vector Manufacturing Market Competitive Landscape And Company Profiles

    30.1. Viral And Non-Viral Vector Manufacturing Market Competitive Landscape

    30.2. Viral And Non-Viral Vector Manufacturing Market Company Profiles

    30.2.1. Novartis AG

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Thermo Fisher Scientific Inc.

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Merck KGaA

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. FUJIFILM Holdings Corporation

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Regeneron Pharmaceuticals Inc.

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Viral And Non-Viral Vector Manufacturing Market Other Major And Innovative Companies

    31.1. Astellas Pharma Inc.

    31.2. Lonza Group AG

    31.3. WuXi AppTec Co Ltd.

    31.4. Catalent Inc.

    31.5. Sartorius AG

    31.6. Charles River Laboratories Inc.

    31.7. Sarepta Therapeutics Inc.

    31.8. GenScript ProBio Co. Ltd.

    31.9. TAKARA BIO Inc.

    31.10. Oxford BioMedica plc

    31.11. Beam Therapeutics Inc.

    31.12. Intellia Therapeutics Inc.

    31.13. MaxCyte Inc.

    31.14. Voyager Therapeutics Inc.

    31.15. Genethon

    32. Global Viral And Non-Viral Vector Manufacturing Market Competitive Benchmarking

    33. Global Viral And Non-Viral Vector Manufacturing Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Viral And Non-Viral Vector Manufacturing Market

    35. Viral And Non-Viral Vector Manufacturing Market Future Outlook and Potential Analysis

    35.1 Viral And Non-Viral Vector Manufacturing Market In 2028 - Countries Offering Most New Opportunities

    35.2 Viral And Non-Viral Vector Manufacturing Market In 2028 - Segments Offering Most New Opportunities

    35.3 Viral And Non-Viral Vector Manufacturing Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Viral And Non-Viral Vector Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Viral And Non-Viral Vector Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Asia-Pacific, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: China, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: India, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: Japan, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Australia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Indonesia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: South Korea, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: Western Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: UK, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: Germany, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: France, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: Italy, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Spain, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Eastern Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Russia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: North America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: USA, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: Canada, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: South America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: Brazil, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Middle East, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Africa, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Novartis AG Financial Performance
  • Table 75: Thermo Fisher Scientific Inc. Financial Performance
  • Table 76: Merck KGaA Financial Performance
  • Table 77: FUJIFILM Holdings Corporation Financial Performance
  • Table 78: Regeneron Pharmaceuticals Inc. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Viral And Non-Viral Vector Manufacturing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Viral And Non-Viral Vector Manufacturing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Asia-Pacific, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: China, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: India, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: Japan, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Australia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Indonesia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: South Korea, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: Western Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: UK, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: Germany, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: France, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: Italy, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Spain, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Eastern Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Russia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: North America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: USA, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: Canada, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: South America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: Brazil, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Middle East, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Africa, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Vector Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Viral And Non-Viral Vector Manufacturing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Novartis AG Financial Performance
  • Figure 75: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 76: Merck KGaA Financial Performance
  • Figure 77: FUJIFILM Holdings Corporation Financial Performance
  • Figure 78: Regeneron Pharmaceuticals Inc. Financial Performance
Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis
Read More
How Will The Nuclear Medicine Market Grow In 2022?
Read More
What Is The Pediatric Imaging Market Overview In 2022?
Read More
Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company
Read More
The Business Research Company offers the hospital acquired infection control market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the multiplex assays market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the healthcare it consulting market research report 2022 with industry size, share, segments and market growth
Read More
The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth
Read More
Viral Vectors And Plasmid DNA Global Market Report 2024 – By Product (Plasmid DNA, Viral Vectors), By Disease (Infectious Diseases, Genetic Disorders, Cancer, Other Diseases), By Application (Gene And Cancer Therapies, Viral Infections, Immunotherapy, Formulation Development, Other Applications), By End User (Research Institutes, Biopharmaceutical And Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Vector Control Global Market Report 2024 – By Method of Control (Chemical, Physical and Mechanical, Biological, Other Method Of Control), By Vector Type (Insects, Rodents, Other Vector Types), By Application (Residential, Commercial, Industrial) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Viral Inactivation Global Market Report 2024 – By Product (Kits And Reagents, Systems, Services), By Method (Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods), By Application (Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications), By End User (Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Viral Gastroenteritis Global Market Report 2024 – By Drugs (Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs), By Diagnosis (Physical Examination, Rapid Stool Test), By Indication (Watery Diarrhea, Abdominal Cramps, Pain, Other Indications), By Type Of Virus (Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus), By End User (Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Viral Vector Manufacturing Global Market Report 2024 – By Type (Adenoviral Vectors, Adeno-Associated Viral Vectors, Lentiviral Vectors, Retroviral Vectors, Other Types), By Disease (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Workflow (Upstream Processing, Downstream Processing), By Application (Gene And Cell Therapy Development, Vaccine Development, Biopharmaceutical And Pharmaceutical Discovery, Biomedical Research), By End-User (Research Organizations, Biotech And Pharmaceutical Companies, Others End Users) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Manufacturing Execution System Global Market Report 2024 – By Offering (Software, Services), By Deployment (On-premise, On-demand, Hybrid), By Organization Size (Small and Medium Size Enterprise, Large Enterprise), By Process Industry (Food & Beverages, Oil & Gas, Chemicals, Pulp & Paper, Pharmaceutical & Life Sciences, Energy & Power, Water & Wastewater Management, Other Process Industries) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antivirals Global Market Report 2024 – By Type (Branded, Generic), By Drug Class (DNA Polymerase Inhibitors, Reverse Transcriptase Inhibitors, Protease Inhibitors, Neuraminidase Inhibitors, Other Drug classes), By Application (HIV, Hepatitis, Herpes, Influenza, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033
View Report
Antiviral Combination Therapy Global Market Report 2024 – By Type (Branded, Generic), By Drug Combination (Nucleotide Reverse Transcriptase Inhibitors/Non-Nucleotide Reverse Transcriptase Inhibitors, Integrase Inhibitor/Nucleotide Reverse Transcriptase Inhibitors, Nucleotide Reverse Transcriptase Inhibitors, Nucleotide Reverse Transcriptase Inhibitors/Protease Inhibitor, Other Drug Combinations), By Route Of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Other Distribution Channels), By Indication (Human Immunodeficiency Virus, Hepatitis, Other Indications) – Market Size, Trends, And Global Forecast 2024-2033
View Report

Frequently Asked Questions

What is the definition of the viral and non-viral vector manufacturing market?

Viral and non-viral vector manufacturing refers to producing viral and non-viral vectors, tools that deliver genetic material into cells. Viral vectors treat human diseases and are used in anticancer and gene therapies. Non-viral vectors are utilized for a variety of gene therapy applications, particularly for the creation of vaccines and the treatment of cancer. For further insights on the viral and non-viral vector manufacturing market, request a sample here

How will the viral and non-viral vector manufacturing market drivers and restraints affect the viral and non-viral vector manufacturing market dynamics? What forces will shape the viral and non-viral vector manufacturing industry going forward?

The viral and non-viral vector manufacturing market major growth driver - The Rise Of Vector Therapies In Genetic Disorder Treatment. For further insights on the viral and non-viral vector manufacturing market, request a sample here

What is the forecast market size or the forecast market value of the viral and non-viral vector manufacturing market?

The viral and non-viral vector manufacturing market size has grown rapidly in recent years. It will grow from $7.22 billion in 2023 to $8.62 billion in 2024 at a compound annual growth rate (CAGR) of 19.5%. The growth in the historic period can be attributed to rising prevalence of genetic disorders, advancements in biotechnology, increasing investments in gene therapy research, growing awareness of personalized medicine, regulatory support for gene therapy development. The viral and non-viral vector manufacturing market size is expected to see rapid growth in the next few years. It will grow to $17.85 billion in 2028 at a compound annual growth rate (CAGR) of 20.0%. The growth in the forecast period can be attributed to rising demand for gene therapies, expanding applications in rare diseases treatment, increasing investments in biomanufacturing infrastructure, growing adoption of precision medicine. Major trends in the forecast period include development of next-generation viral vectors, increased use of crispr/cas9 technology in vector manufacturing, focus on scalable and cost-effective manufacturing processes, rising adoption of non-viral vectors, advancements in cell and gene therapy manufacturing technologies. For further insights on the viral and non-viral vector manufacturing market, request a sample here

How is the viral and non-viral vector manufacturing market segmented?

The viral and non-viral vector manufacturing market is segmented
1) By Vector Type: Viral Vector, Non-Viral Vector
2) By Disease: Cancer, Genetic Disease, Infectious Disease, Cardiovascular Disease, Other Diseases
3) By Application: Gene Therapy, Vaccinology, Cell Therapy, Other ApplicationsFor further insights on the viral and non-viral vector manufacturing market, request a sample here

Which region has the largest share of the viral and non-viral vector manufacturing market? What are the other regions covered in the report?

North America was the largest region in the viral and non-viral vector manufacturing market in 2023. The regions covered in the viral and non-viral vector manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa For further insights on the viral and non-viral vector manufacturing market, request a sample here.

Who are the major players in the viral and non-viral vector manufacturing market?

Major companies operating in the viral and non-viral vector manufacturing market report are Novartis AG, Thermo Fisher Scientific Inc., Merck KGaA, FUJIFILM Holdings Corporation, Regeneron Pharmaceuticals Inc., Astellas Pharma Inc., Lonza Group AG, WuXi AppTec Co Ltd., Catalent Inc., Sartorius AG, Charles River Laboratories Inc., Sarepta Therapeutics Inc., GenScript ProBio Co. Ltd., TAKARA BIO Inc., Oxford BioMedica plc, Beam Therapeutics Inc., Intellia Therapeutics Inc., MaxCyte Inc., Voyager Therapeutics Inc., Genethon, MeiraGTx Holdings plc, Evox Therapeutics Ltd., Entos Pharmaceuticals Inc., LogicBio Therapeutics Inc., bluebird bio Inc., 4D Molecular Therapeutics Inc., Precision NanoSystems Inc., GenSight Biologics S.A., Abeona Therapeutics Inc., Generation Bio Co. For further insights on the viral and non-viral vector manufacturing market, request a sample here.

What are the key trends in the viral and non-viral vector manufacturing market?

Major trend in the viral and non-viral vector manufacturing market - Merck Kgaa’S Breakthrough In Viral And Non-Viral Solutions. For further insights on the viral and non-viral vector manufacturing market, request a sample here.

What are the major opportunities in the viral and non-viral vector manufacturing market? What are the strategies for the viral and non-viral vector manufacturing market?

For detailed insights on the major opportunities and strategies in the viral and non-viral vector manufacturing market, request a sample here.

How does the viral and non-viral vector manufacturing market relate to the overall economy and other similar markets?

For detailed insights on viral and non-viral vector manufacturing market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the viral and non-viral vector manufacturing industry?

For detailed insights on the mergers and acquisitions in the viral and non-viral vector manufacturing industry, request a sample here.

What are the key dynamics influencing the viral and non-viral vector manufacturing market growth? SWOT analysis of the viral and non-viral vector manufacturing market.

For detailed insights on the key dynamics influencing the viral and non-viral vector manufacturing market growth and SWOT analysis of the viral and non-viral vector manufacturing industry, request a sample here.